C4 Therapeutics, Inc.

CCCC Nasdaq CIK: 0001662579

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 490 ARSENAL WAY, WATERTOWN, MA, 02472
Mailing Address 490 ARSENAL WAY, WATERTOWN, MA, 02472
Phone (617) 231-0700
Fiscal Year End 1231
EIN 475617627

Financial Overview

FY2024

-$105.32M
Net Income

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 12, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 11, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
8-K Current report of material events January 14, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
424B5 Prospectus supplement December 10, 2025 View on SEC
S-3 Shelf registration for future offerings November 21, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 14, 2025 View on SEC
SCHEDULE 13G/A Passive ownership amendment November 13, 2025 View on SEC

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.